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A B S T R A C T
Objectives: The aim of this study was to assess HIV modes of exposure in Morocco at the national level and
also for Souss-Massa-Drâa, the region most affected by HIV. Another aim was to assess the impact of
different scenarios of select intervention packages.
Methods: The Modes of Transmission Model was adapted and used, and was parameterized using quality
bio-behavioral surveillance data among key populations, routine data sources, and literature reviews.
Results: Nationally in 2013, the largest number of new infections occurred among clients of female sex
workers (FSWs) (25%; 95% conﬁdence interval (CI) 14–37%), followed by men who have sex with men
(MSM) (22%; 95% CI 12–35%), HIV serodiscordant couples (22%; 95% CI 12–34%), FSWs (11%; 95% CI 6–
18%), and people who inject drugs (5%; 95% CI 2–9%). A similar pattern of results was observed in Souss-
Massa-Drâa, but the HIV incidence rate was four-fold that at the national level. Different scenarios of
feasible intervention packages reduced HIV incidence by 8–44%.
Conclusions: Commercial heterosexual sex networks continue as the leading driver of the epidemic, with
half of HIV incidence. A quarter of new infections occurred among MSM, a third of which in Souss-Massa-
Drâa. Feasible expanded coverage of interventions could lead to large reductions in incidence.
© 2017 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
Introduction
Although the HIV epidemic is receding globally, it appears to be
expanding in the Middle East and North Africa (MENA) (UNAIDS,
2016). HIV epidemics in MENA, many of which are emerging, have
been documented among people who inject drugs (PWID), men
who have sex with men (MSM), and female sex workers (FSWs),
with heterogeneity between countries on the relative role of each
of these key populations (Abu-Raddad et al., 2010a,b; Mumtaz
et al., 2011, 2014a,b).
Morocco is the most outstanding country in MENA in
confronting the epidemic through an evidence-informed and
comprehensive response (Mumtaz et al., 2013, 2018; Kouyoumjian
et al., 2013; Bennani et al., 2014). As part of this effort, Morocco
conducted a national HIV Modes of Transmission (MoT) analysis in
2010. This analysis highlighted the need to focus the HIV response
on key populations through the development of proactive and
sustainable HIV surveillance, as well as ensuring a wider coverage
of condom use programming, voluntary counseling and testing
(VCT) services, and harm reduction and treatment units.
Consequently, as part of national HIV surveillance expansion
activities, Morocco conducted ﬁrst rounds of integrated bio-
behavioral surveillance surveys (IBBSS) among FSWs in Agadir, Fes,
Rabat, and Tanger (Johnston, 2011a), MSM in Agadir and
Marrakech (Johnston, 2011b), and PWID in Tanger and Nador
(Johnston, 2012), using state-of-the-art sampling methodologies
for hidden and hard-to-reach populations, such as respondent-
driven sampling. This quality evidence facilitated an analysis of HIV
exposure and incidence to inform policy and programming
decisions through a framework of ‘know your epidemic, know
your response’ (Wilson and Halperin, 2008).
Against this background, the objectives of the present study
were (1) to update the 2010 Morocco National HIV MoT Model
results factoring in the newly available IBBSS and other data up to
2013 (Mumtaz et al., 2013, 2018); (2) to analyze the distribution of
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new HIV infections by mode of exposure in the region of the
country most affected by HIV, Souss-Massa-Drâa; (3) to assess the
impact of several HIV prevention and treatment interventions,
including increasing antiretroviral therapy (ART) coverage, con-
dom use, and (for PWID) harm reduction (reducing current sharing
of needles and syringes). This article summarizes the results and
ﬁndings of the study, based on a detailed report of the results
presented to the Morocco Ministry of Health and other HIV
stakeholders in Morocco, to inform HIV policy and programming in
this country (Bennani et al., 2014).
Methods
Sources of data
The IBBSS studies among FSWs (Johnston, 2011a), MSM
(Johnston, 2011b), and PWID (Johnston, 2012), were provided by
the Morocco Ministry of Health, in addition to sentinel surveil-
lance, VCT, notiﬁed HIV/AIDS cases, and ART data, among others.
Further data were retrieved from extensive state-of-the-art
systematic reviews (Kouyoumjian et al., 2013; Mumtaz et al.,
2010, 2014a) of HIV data and related outcomes in MENA that were
conducted as informed by the Cochrane Collaboration handbook
(The Cochrane Collaboration, 2008) and reported following the
Preferred Reporting Items for Systematic Reviews and Meta-
analyses (PRISMA) guidelines (Moher et al., 2009), as well as from
the MENA HIV/AIDS Epidemiology Synthesis Project database
(Abu-Raddad et al., 2010a,b) and an updated literature search of
data from Morocco.
Model structure, model parameterization, and uncertainty analyses
A description of the MoT Model structure is provided in
Section 1 of the Supplementary Material and in the 2010 MoT study
(Mumtaz et al., 2013). The model parameters for both the National
MoT Model study and the regional Souss-Massa-Drâa MoT Model
study were primarily based on the IBBSS and other data from
Morocco, as described above, in addition to regional and global HIV
data, and consensus of national stakeholders (Section 2, Supple-
mentary Material).
Table S1.1 in the Supplementary Material provides key
deﬁnitions used to classify individuals by risk group in the model.
Table S2.1 of the Supplementary Material summarizes the
biological parameters of the model. Table S2.2 of the Supplemen-
tary Material (National) and Table S3.1 of the Supplementary
Material (Souss-Massa-Drâa) provide the key demographic attrib-
utes. Table S2.3 of the Supplementary Material (National) and
Table S3.2 of the Supplementary Material (Souss-Massa-Drâa)
include the risk group size estimates for each HIV risk group.
Table S2.4 of the Supplementary Material (National) and Table S3.3
of the Supplementary Material (Souss-Massa-Drâa) show HIV
prevalence for each HIV risk group. Table S2.5 of the Supplemen-
tary Material (National) and Table S3.4 of the Supplementary
Material (Souss-Massa-Drâa) tabulate the risk behavior param-
eters for each HIV risk group.
Uncertainty analysis
The model parameters were varied simultaneously and
randomly within a range of uncertainty of 25% around each
parameter value (Table S4.1, Supplementary Material). The range of
plausibility for the total annual incidence was determined by the
range obtained from the UNAIDS SPECTRUM model (UNAIDS,
2013), as applied for Morocco in 2012 (Morocco Ministry of Health/
National AIDS Program, 2013). The median of all selected plausible
outputs was then calculated and the uncertainty was described by
plausibility bounds deﬁned as the 2.5 and 97.5 percentiles. Further
details of the National and Souss-Massa-Drâa MoT Model
uncertainty analyses are found in Section 4 of the Supplementary
Material.
Assessment of the impact of the select interventions on HIV incidence
The impact of several HIV prevention and treatment inter-
ventions targeted at people living with HIV (PLHIV), key
populations, and stable heterosexual couples (i.e., HIV serodis-
cordant couples) were examined. The intervention packages were
designed based on relevance to the National AIDS Program of
Morocco, as well as what could be reasonable and feasible
immediate targets given the 2013 ART coverage of only 20% among
Table 1
Select HIV prevention and treatment intervention packages targeted at people living with HIV, key populations, and HIV serodiscordant couples in Morocco.
Intervention Description
ART intervention packages
Increasing ART coverage for PLHIV with different CD4 levels 80% ART coverage for PLHIV with CD4 <350 cells/ml
50% ART coverage for PLHIV with CD4 <500 cells/ml
60% ART coverage for PLHIV with CD4 <500 cells/ml
70% ART coverage for PLHIV with CD4 <500 cells/ml
Increasing ART coverage for PLHIV with different CD4 levels, key
populations, and HIV serodiscordant couples
80% ART coverage for PLHIV with CD4 <350 cells/ml
50% ART coverage for PLHIV with CD4 <500 cells/ml, 50% coverage for key populations,
and 30% for HIV serodiscordant couples
60% ART coverage for PLHIV with CD4 <500 cells/ml, 60% coverage for key populations,
and 40% for HIV serodiscordant couples
70% ART coverage for PLHIV with CD4 <500 cells/ml, 70% coverage for key populations,
and 50% for HIV serodiscordant couples
Condom use intervention package
Increasing current condom use coverage among FSWs, clients of FSWs, and
MSM
by 25%
by 50%
by 75%
by 100%
Harm reduction intervention package
Reducing current sharing of needles and syringes among PWID by 25%
by 50%
by 75%
ART, antiretroviral therapy; PLHIV, people living with HIV; FSWs, female sex workers; MSM, men who have sex with men; PWID, people who inject drugs.
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PLHIV. Speciﬁcally, these intervention packages have been
designed based on consensus of national HIV stakeholders in
Morocco and taking into account funding availability, experience
in the ﬁeld, and logistical considerations. The distributions of the
PLHIV population by CD4 count and of ART coverage levels across
these populations were determined based on the outputs of the
Morocco SPECTRUM model 2012 (UNAIDS, 2013; Morocco Ministry
of Health/National AIDS Program, 2013).
Table 1 summarizes the intervention packages examined.
Different scenarios of four select intervention packages were
speciﬁcally examined, including (1) expansion of ART coverage
through two different intervention packages as informed by the
adopted National Guidelines of 2013 and the National Strategic
Plan of 2016; (2) increasing condom use coverage among FSWs,
clients of FSWs, and MSM; and (3) increasing harm reduction
coverage among PWID by reducing sharing of needles and syringes.
Results
Risk group size estimates for each HIV risk group for both the
National and Souss-Massa-Drâa MoT analyses are listed in Table 2.
The distribution of new HIV infections by mode of exposure for
both the National and Souss-Massa-Drâa MoT analyses are shown
in Table 3. These are also schematized in Figure 1, along with the
uncertainty around the model predictions. The results of the
analyses on the MoT Model predictions for both the National and
Souss-Massa-Drâa MoT Models are tabulated in Table 4.
National Modes of Transmission analysis
Population groups engaged in commercial heterosexual sex
were the largest of all key populations in Morocco, including an
estimated 85 000 FSWs and 850 000 clients (Table 2). MSM came
second with 55 319 individuals, and PWID third with 5000
individuals (Table 2). Just over 5% of the 15–49 years of age
population (9.5% of males and 0.9% of females) engaged in high-
risk behaviors, mostly as clients of FSWs (Table 4). Less than 2% of
the 15–49 years of age population were in stable partnerships with
partners engaging in high-risk behaviors, and were therefore at
higher risk of being exposed to HIV; these were mostly women
(Table 4).
The largest contribution to HIV incidence (number of new
infections per year) was among clients of FSWs (25%; 95%
conﬁdence interval (CI) 14–37%), followed by MSM (22%; 95% CI
12–35%), stable heterosexual couples (corresponding to HIV
serodiscordant couples; 22%; 95% CI 12–34%), and FSWs (11%;
95% CI 6–18%) (Table 3). The networks of these population groups,
i.e., these groups along with their stable sexual partners,
contributed at least 70% (95% CI 57–81%) of HIV incidence (Table 4).
Speciﬁcally, commercial heterosexual sex networks contributed
41% (95% CI 27–56%) of incidence, followed by MSM networks
(24%; 95% CI 13–37%) and PWID networks (6%; 95% CI 3–10%)
(Table 4). The remaining one-third of incidence was among stable
heterosexual couples (HIV serodiscordant couples) and people
engaged in casual heterosexual sex (Table 4).
About half (44%) of HIV incidence in Morocco was among
women, but 73% of all infections among women were transmitted
by an infected spouse (Table 4). Most infections (92%) among men
were due to high-risk practices (Table 4). The HIV incidence rate
was highest among PWID at 3.4% per person-year, followed by
MSM at 1.3% and FSWs at 0.4% (Table 3). If these incidence rates
remain constant, HIV prevalence may reach, at endemic equilibri-
um, levels as high as 17% among PWID, 10% among MSM, and 3%
among FSWs (Table 3). These estimates at endemic equilibrium
were not generated using the MoT Model but using a complemen-
tary deterministic competing-hazards differential-equations mod-
el that included as an input the HIV force of infection (HIV
incidence rate) generated by the MoT Model.
Souss-Massa-Drâa Modes of Transmission analysis
Population groups engaged in commercial heterosexual sex
were the largest of all key population groups in Souss-Massa-Drâa,
including an estimated 11363 FSWs and 113 630 clients (Table 2).
MSM came second with 13 080 individuals, and PWID third with an
estimate of only 100 individuals (Table 2). About 10% of the 15–49
years of age population (17.8% of men and 1.6% of women) engaged
in high-risk behaviors, mostly as clients of FSWs (Table 4). Less
than 4% of the 15–49 years of age population were in stable
partnerships with partners engaging in high-risk behaviors, and
were therefore at higher risk of being exposed to HIV; these were
mostly women (Table 4).
Table 2
Risk group size estimates for each HIV risk group in the National and Souss-Massa-Drâa Modes of Transmission Model analyses in Morocco, 2013.
Population Prevalence of risk (%)
(National)
Population size estimate (N)
(National)
Prevalence of risk (%)
(Souss-Massa-Drâa)
Population size estimate (N)
(Souss-Massa-Drâa)
Total Male Female Total Male Female Total Male Female Total Male Female
PWID 0.026 0.047 0.005 5000 4480 520 0.007 0.013 0.001 100 90 10
Stable sexual partners of PWID 0.015 0.003 0.027 2890 301 2589 0.004 0.001 0.007 58 6 52
FSWs 0.444 – 0.888 85 000 – 85 000 0.796 – 1.593 11 363 – 11 363
Clients of FSWs 4.439 8.877 – 850 000 850 000 – 7.965 15.929 – 113 630 113 630 –
Stable sexual partners of FSWs’
clients
1.775 – 3.551 340 000 – 340 000 3.186 – 6.372 45 452 – 45 452
MSM 0.289 0.578 – 55 319 55 319 – 0.917 1.834 – 13 080 13 080 –
Stable female partners of MSM 0.122 – 0.243 23 278 – 23 278 0.386 – 0.772 5504 – 5504
People engaged in casual heterosexual
sex
5.5 10.0 1.0 1 053 243 957 494 95 749 5.5 10.0 1.0 78 467 71 334 7133
Stable partners of people engaged in
casual heterosexual sex
2.525 0.050 5.000 483 534 4787 478 747 2.525 0.050 5.0000 36 024 357 35 667
People engaged in stable heterosexual
partnerships
57.365 60.445 54.286 10 985 397 5 787 570 5 197 827 51.214 52.174 50.255 730 665 372 176 358 489
People with no risk this year 27.50 20.00 35.00 5 266 216 1 914 988 3 351 228 27.50 20.00 35.00 392 337 142 668 249 669
Population at risk of medical injections 100 100 100 19 149 878 9 574 939 9 574 939 100 100 100 1 426 680 713 340 713 340
Population at risk of blood transfusions 0.364 0.364 0.364 69 750 34 875 34 875 0.364 0.364 0.364 9465 4732.5 4735.2
PWID, people who inject drugs; FSWs, female sex workers; MSM, men who have sex with men.
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The largest contribution to HIV incidence in Souss-Massa-Drâa
was among clients of FSWs (27%; 95% CI 15–39%), followed by MSM
(26%; 95% CI 13–41%), FSWs (19%; 95% CI 11–30%), and stable
heterosexual couples (i.e., HIV serodiscordant couples; 12%; 95% CI
3–25%) (Table 3). The networks of these population groups
contributed at least 83% (95% CI 69–92%) of HIV incidence (Table 4).
Speciﬁcally, commercial heterosexual sex networks contributed
55% (95% CI 39–72%) of incidence, followed by MSM networks
(27%; 95% CI 15–43%) and PWID networks (0.10%; 95% CI 0.05–
0.20%) (Table 4). The remaining incidence was among stable
heterosexual couples (HIV serodiscordant couples) and people
engaged in casual heterosexual sex (Table 4).
About half (45%) of HIV incidence in Souss-Massa-Drâa was
among women, but 57% of all infections among women were
transmitted by an infected spouse (Table 4). Most infections (95%)
among men were due to high-risk practices (Table 4). The HIV
incidence rate was highest among MSM at 2.0% per person-year,
followed by FSWs at 1.7% and PWID at 0.9% (Table 3). If these
incidence rates remain constant, HIV prevalence may reach, at
endemic equilibrium, levels as high as 14% among MSM, 9% among
FSWs, and 5% among PWID (Table 3).
Impact of select interventions on HIV incidence
Figure 2A shows the impact of the four scenarios in the ﬁrst ART
intervention package in which ART coverage is scaled up to 80%
among PLHIV with a CD4 count <350 cells/ml, or to 50%, 60%, and
70%, respectively, among PLHIV with a CD4 count <500 cells/ml.
HIV incidence for 2013 was reduced through this package by 8–
27%, thereby averting 247–855 new HIV infections.
Figure 2B shows the impact of the four scenarios in the second
ART intervention package. This package compares an ART coverage
of 80% among PLHIV with a CD4 count <350 cells/ml to three other
scenarios where ART coverage is scaled up to 50%, 60%, and 70%,
respectively, among both PLHIV with a CD4 count <500 cells/ml
and key populations (FSWs, clients of FSWs, MSM, and PWID)
while simultaneously expanding ART coverage to 30%, 40%, and
50%, respectively, among HIV serodiscordant couples. HIV
Table 3
Key predictions of the National and Souss-Massa-Drâa Modes of Transmission Model analyses in Morocco, 2013.
National MoT Model HIV
prevalence
(%)
Number
of PLHIV
HIV
incidence
Percentage of
total incidence
(%)
Incidence
among
males
Incidence
among
females
Incidence of
females/total
(%)
HIV incidence per
person-year (%)
Equilibrium
prevalence (forecast)
(%)a
Population
PWID 9.00 450 153 4.84 137 16 10.4 3.37 16.81
Sexual partners of
PWID
3.00 87 25 0.80 3 23 89.6 0.90 7.80
FSWs 2.04 1734 350 11.08 0 350 100.0 0.42 2.46
Clients 0.38 3230 780 24.65 780 0 0.0 0.09 0.55
Partners of clients 0.19 646 163 5.17 0 163 100.0 0.05 0.45
MSM 3.00 1660 708 22.39 708 0 0.0 1.32 10.16
Female partners
of MSM
0.75 175 45 1.42 0 45 100.0 0.19 1.44
Casual heterosexual
sex
0.28 2908 82 2.58 74 7 9.1 0.01 0.06
Partners of casual
heterosexual sex
0.14 668 168 5.31 2 166 99.0 0.03 0.33
Stable heterosexual
partnerships
0.07 7690 683 21.59 60 622 91.2 0.01 0.06
No risk 0.07 3686 0 0.00 – – – – –
Medical injections 0.14 – 4 0.13 2 2 50.0 0.00 –
Blood transfusions 0.02 – 1 0.03 0 0 50.0 0.00 –
Total adult
population
0.12 22 933 3163 100.0 1767 1396 44.1 0.02 –
Souss-Massa-Drâa
MoT Model
HIV
prevalence
(%)
Number
of PLHIV
HIV
incidence
Percentage of
total incidence
(%)
Incidence
among
males
Incidence
among
females
Incidence of
females/total
(%)
HIV incidence per
person-year (%)
Equilibrium
prevalence (forecast)
(%)a
Population
PWID 2.30 2 1 0.09 1 0 10.4 0.87 4.95
Sexual partners of
PWID
0.77 0 0 0.01 0 0 89.6 0.23 2.12
FSWs 5.10 580 185 19.39 0 185 100.0 1.71 9.32
Clients 1.58 1795 253 26.60 253 0 0.0 0.23 1.34
Partners of clients 0.79 359 90 9.48 0 90 100.0 0.20 1.84
MSM 4.75 621 243 25.52 243 0 0.0 1.95 14.33
Female partners
of MSM
1.19 65 17 1.76 0 17 100.0 0.31 2.26
Casual heterosexual
sex
0.70 549 15 1.61 14 1 9.1 0.02 0.15
Partners of casual
heterosexual sex
0.35 126 32 3.32 0 31 99.0 0.09 0.82
Stable heterosexual
couples
0.18 1279 115 12.08 10 105 91.5 0.02 0.15
No risk 0.18 706 0 0.00 – – – – –
Medical injections 0.40 – 1 0.11 1 1 50.0 0.00 –
Blood transfusions 0.05 – 0 0.04 0 0 50.0 0.00 –
Total adult
population
0.43 6084 953 100.0 522 431 45.2 0.07 –
MoT, Modes of Transmission; PLHIV, people living with HIV; PWID, people who inject drugs; FSWs, female sex workers; MSM, men who have sex with men.
a Forecast assuming persistence of the current HIV incidence rate as predicted by the MoT Model.
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incidence for 2013 was reduced through this package by 8–44%,
thereby averting 247–1403 new HIV infections.
Figure 2C shows the impact of the four scenarios of the condom
intervention package that expands condom use coverage among
FSWs, clients of FSWs, and MSM by 25%, 50%, 75%, and 100%,
respectively. Relative to current condom use coverage, HIV
incidence among these three population groups for 2013 was
reduced through this package by 10–39%, thereby averting 177–711
new HIV infections.
Figure 2D shows the impact of the three scenarios of the harm
reduction intervention package that reduces sharing of needles
and syringes among PWID. By reducing sharing of needles and
syringes by 25–75%, relative to the current level of sharing, HIV
incidence among PWID for 2013 was reduced by 24–73%, thereby
averting 36–112 new HIV infections.
Discussion
This study provided a mapping of HIV exposures in Morocco at
the national level, as well as for Souss-Massa-Drâa, the region most
affected by the epidemic. The 2010 National MoT analysis (Mumtaz
et al., 2013) was ﬁrst updated based on quality IBBSS data that
became available recently. It was found that commercial hetero-
sexual sex networks continue to be the leading driver of the
epidemic in this country, but that there is a growing contribution
for MSM. Nearly a quarter of new HIV infections in 2013 occurred
among MSM. While the pattern of HIV exposures in Souss-Massa-
Drâa largely mirrored the national pattern, the HIV incidence rate
was four-fold higher. Nearly a third of new HIV infections in
Morocco occurred in this region. Although Morocco has estab-
lished an array of HIV prevention and treatment programs that
reduced HIV transmission, further reductions are possible with
feasible expansion of these programs to reach higher service
coverage.
The HIV incidence in Morocco did not change appreciably over
the years 2010–2013, but it seemed to be on a slow declining trend
(Table 3 versus 2010 MoT Model analysis (Mumtaz et al., 2013)).
The networks of FSWs and their clients, MSM, and PWID are the
core drivers of the HIV epidemic in Morocco, contributing two-
thirds of total HIV incidence (Table 4). Following a regional trend
(Mumtaz et al., 2011, 2014b), HIV transmission among MSM is
apparently becoming, or has just been recognized with the recent
availability of quality data for this population, a key feature of the
epidemic in Morocco. The epidemic in commercial heterosexual
sex networks and MSM appears to be most intense in the south of
Morocco, and especially in Souss-Massa-Drâa (Figure S5.1,
Supplementary Material). For PWID, most transmission appears
to be in the north of Morocco (Johnston, 2012) (Figure S5.1,
Supplementary Material), although knowledge of this population
group remains insufﬁcient to reach conclusive ﬁndings.
The predictions of the National and Souss-Massa-Drâa MoT
Models show that men and women contribute nearly equally to
HIV incidence (Table 3), in agreement with the distribution among
notiﬁed cases (Ministère de la Santé au Maroc and null, 2013).
However, most women acquired the infection from their infected
spouses (Table 4), highlighting the vulnerability of women in HIV
Figure 1. Distribution of new HIV infections by mode of exposure and the uncertainty in the Morocco Modes of Transmission Model predictions, 2013. (A) Morocco National
MoT model predictions. (B) Souss-Massa-Drâa MoT Model predictions.
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serodiscordant couples as seen in other MENA countries (Abu-
Raddad et al., 2010a).
The Souss-Massa-Drâa MoT Model analysis provided the ﬁrst
regional MoT application in MENA. The main features of its ﬁndings
agreed with those of the National MoT Model analysis (Tables 3 and
4). Similarly, networks of FSWs and their clients, MSM, and PWID
were the core drivers of the HIV epidemic in Souss-Massa-Drâa,
contributing 83% of total HIV incidence (Table 4).
Although the pattern of HIV exposures in Souss-Massa-Drâa
largely mirrored the national pattern, there are key features that
distinguish the epidemic in Souss-Massa-Drâa (Tables 3 and 4). The
HIV incidence rate in Souss-Massa-Drâa was four-fold that at the
national level, afﬁrming the disproportionate role of this region in
the epidemic. Commercial heterosexual sex networks played a
larger and dominant role in the Souss-Massa-Drâa epidemic,
contributing two-thirds of total HIV incidence. MSM networks
appeared also to play a larger role here than at the national level,
contributing 27% of HIV incidence. Nonetheless, there is apparently
limited injecting drug use in this part of Morocco, with minimal
contribution of this mode of exposure to the epidemic.
The susceptibility of Souss-Massa-Drâa to a more intense HIV
epidemic may relate to the high mobility characterizing this
region. Indeed, Souss-Massa-Drâa is a primary tourism hub in
Morocco and the center of an agricultural production area that
attracts a large number of poor seasonal migrant laborers from
different parts of the country.
Morocco accomplished signiﬁcant strides in scaling-up HIV
interventions among key populations, but there is much room for
improvement for a better epidemic control. In 2012, there were
5301 HIV-infected people on ART out of an estimated 30 000 PLHIV
(Morocco Ministry of Health/National AIDS Program, 2013).
Despite the achievement in establishing and expanding ART access
and coverage, the coverage is still well below what is desired in
light of current World Health Organization guidelines (World
Health organization, 2015a,b). The present study results indicate
that much can be gained in HIV incidence reduction by expanding
ART coverage and other interventions such as condom use and
harm reduction (Figure 2). The focus of these interventions should
be among key groups, as their transmission networks are the main
drivers of the epidemic.
The limitations of this study arise from the limitations of the
MoT Model’s structure and the data input used to parameterize the
model, as described in detail previously (Mumtaz et al., 2013;
Gouws et al., 2012; Case et al., 2012a). Brieﬂy, the model, for
instance, does not account for heterogeneity in the risk of exposure
to HIV infection in the different population groups including, for
example, among stable heterosexual couples (Case et al., 2012b;
Borquez et al., 2016), across regions or subregions (Borquez et al.,
2016), or by HIV infectiousness for different infection stages (Case
et al., 2012b; Mishra et al., 2014). The static model structure also
does not accommodate competing risks/multiple sources of
exposure. Populations are classically classiﬁed based on the source
of exposure that presents the highest risk for infection acquisition
(Case et al., 2012b; Mishra et al., 2014). Long chains of secondary
HIV transmissions initiated through high-risk behaviors among
key populations are also not captured using this parsimonious
model (Mishra et al., 2014). These limitations may introduce
uncertainties in the quantitative predictions and may result in an
underestimation of the contribution of key populations to HIV
incidence (Case et al., 2012b; Borquez et al., 2016; Mishra et al.,
Table 4
Results of analyses on the predictions of the National and Souss-Massa-Drâa Modes of Transmission Model analyses in Morocco, 2013.
Finding National MoT model Souss-Massa-Drâa MoT model
Infections originating from:
CHS networks 40.9% 55.5%
MSM networks 23.8% 27.3%
PWID networks 5.6% 0.1%
Three most at-risk networks (CHS, MSM, PWID) 70.4% 82.8%
Casual heterosexual sex networks 7.9% 4.9%
HIV serodiscordant partnerships among the stable heterosexual couples in the general population 21.6% 12.1%
Parenteral transmissions other than injecting drug use 0.2% 0.1%
Infections among:
Women due to an infected spouse 73.0% 56.6%
Men due to high-risk behavior (CHS, MSM, PWID) 92.0% 95.2%
Partners of high-risk individuals 12.7% 14.6%
Population engaged in high-risk behavior (CHS, MSM, PWID):
Males 9.5% 17.8%
Females 0.9% 1.6%
Adult population 5.2% 9.7%
Fraction of males among population engaged in high-risk behavior 91.4% 91.8%
Fraction of females among population engaged in high-risk behavior 8.6% 8.2%
Population engaged in high-risk behavior (CHS, MSM, PWID) or casual heterosexual sex:
Males 19.5% 27.8%
Females 1.9% 2.6%
Population 10.7% 15.2%
Fraction of males among people engaged in high-risk behavior or casual heterosexual sex 91.2% 91.5%
Fraction of females among people engaged in high-risk behavior or casual heterosexual sex 8.8% 8.5%
Partners of persons engaged in high-risk behavior (CHS, MSM, PWID):
Number 366 168 51014
Fraction of adult population 1.9% 3.6%
Partners of persons engaged in high-risk behavior (CHS, MSM, PWID) or casual heterosexual sex:
Number 849 703 87 038
Fraction of adult population 4.4% 6.1%
MoT, Modes of Transmission; CHS, commercial heterosexual sex; MSM, men who have sex with men; PWID, people who inject drugs.
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2014). Despite these limitations, and until a new methodology of
similar practical use is developed, the MoT Model remains a useful
tool for informing HIV response, as it allows a systematic and
straightforward application using available data.
The quantitative estimates may also have been affected by
uncertainties in input data, particularly in relation to risk group
size estimation and HIV prevalence in the different at-risk
populations. Nevertheless, given the quality IBBSS data used in
the present model application, it is likely that the qualitative
ﬁndings regarding the drivers of HIV incidence are robust. The
uncertainty analyses conducted on the model results support this
conclusion (Figure 1). The predictions of the National and Souss-
Massa-Drâa MoT Models also agree with our understanding of the
HIV epidemic in Morocco based on the outcomes of different
studies of different designs (Mumtaz et al., 2018; Kouyoumjian
et al., 2013). For example, a recent systematic review of multiple
sources of HIV data identiﬁed substantial HIV infection levels
among key populations, with the largest share of new HIV
infections occurring among FSWs and their clients (Kouyoumjian
et al., 2013). The study ﬁndings are also consistent with those of the
earlier 2010 MoT analysis for Morocco, which highlighted the
contributions of high-risk networks, particularly commercial
heterosexual sex networks, to HIV incidence.
This analysis was conducted using data up to the year 2013 and
did not incorporate more recent data, which may have affected
some of the quantitative estimations. However, recent data, in
particular among key populations, suggest that the epidemic is
rather stable and the ﬁndings are representative (Morocco
Ministry of Health/National AIDS Program, 2017). High efﬁcacy
for ART was assumed (based on ﬁndings of a clinical trial) (Cohen
et al., 2011), and this may have slightly inﬂated the estimates for
the impact of ART intervention packages. A ratio of 10 clients per
FSW was also assumed, as informed by (indirect) ﬁndings of
different studies conducted among FSWs in Morocco (Kouyoum-
jian et al., 2013; Johnston, 2011a), as well as ﬁeld experiences of
HIV stakeholders; however, there could be heterogeneity in risk
behavior among FSWs that is difﬁcult to capture using this
parsimonious model.
Conclusions and implications
HIV incidence in commercial heterosexual sex networks
continues as the leading contributor to the epidemic in Morocco.
However, a quarter of HIV incidence occurs among MSM, and this
contribution may be increasing. HIV sexual transmission is most
intense in the Souss-Massa-Drâa region of Morocco, where the HIV
incidence rate is four-fold that at the national level and where one-
third of new HIV infections are occurring.
These ﬁndings shed light on key features of the epidemic in this
country, but several gaps remain. It appears that HIV transmission
among PWID is less intense than that in other MENA countries
(Mumtaz et al., 2014a,b), and mainly focused in the north of
Morocco. Nonetheless, localized and hidden HIV epidemics among
PWID, as well as MSM, might be present in different areas of
Morocco, but are yet to be identiﬁed and characterized, which may
affect their predicted role in the epidemic.
Morocco is recognized for its vigorous, evidence-informed, and
multisectorial HIV response, including the presence of a highly
Figure 2. Impact of select prevention and treatment intervention packages among people living with HIV, key populations, and HIV serodiscordant couples on the predicted
number of new HIV infections compared to the current National Modes of Transmission Model predictions for 2013 (ART, antiretroviral therapy; FSWs, female sex workers;
MSM, men who have sex with men; PLHIV: people living with HIV).
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active civil society and non-governmental organizations working
on HIV prevention and treatment and social support services
(Kouyoumjian et al., 2013; Saba et al., 2013; Abu-Raddad et al.,
2013). Most of the HIV incidence could be controlled by expanding
existing services, such as ART and harm reduction, and focusing the
HIV response on populations most in need of these services
including FSWs and clients, MSM, and PWID. Such an opportunity
to stop the HIV epidemic in Morocco distinguishes this country.
Moreover, the successes of Morocco provide an example and an
opportunity for other MENA countries to strengthen their routine
surveillance, conduct local studies among key populations, and
improve their HIV response, which remains mostly rudimentary.
The HIV response in Morocco also demonstrates the possibility and
feasibility of promoting a detailed and meaningful knowledge of
HIV epidemiology, which remains lacking in other parts of MENA.
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